Vnitr Lek 2016, 62(2):147-151

Fecal microbiota transplantation

Igor Šturdík*, Tibor Hlavatý, Juraj Payer
V. interná klinika LF UK a UN Bratislava, pracovisko Nemocnica Ružinov, Slovenská republika

Fecal microbiota transplantation (FMT) is a therapeutic method, in which the fecal microflora from healthy donors is transmitted to the patient to restore the healthy microbial composition of the gut. In the recent years, there is a growing interest in the therapeutic potential of FMT in various diseases. The standard FMT protocols do not exist. Procedures of FMT vary in several aspects such as donor selection, preparation of fecal material, preparation of the recipient and administration way. FMT appears to be the most successful in the treatment of recurrent Clostridium difficile infection (CDI), randomized controlled studies reported 90 % success rate. There is a limited evidence for FMT as a treatment of ulcerative colitis. FMT has been also studied as treatment of diseases with impaired gut microbiota, such as cardiovascular, autoimmune and metabolic diseases. Many unanswered questions with regard to FMT remain and further research is needed.

Keywords: Clostridium difficile; fecal microbiota transplantation; gut microbiota; inflammatory bowel diseases

Received: October 28, 2015; Accepted: November 23, 2015; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šturdík I, Hlavatý T, Payer J. Fecal microbiota transplantation. Vnitr Lek. 2016;62(2):147-151.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Eiseman B, Silen W, Bascom GS et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44(5): 854-859. Go to PubMed...
    2. Di Bella S, Drapeau C, García-Almodóvar E et al. Fecal microbiota transplantation: the state of the art. Infect Dis Rep 2013; 5(2): e13. Dostupné z DOI: <http://dx.doi.org/10.4081/idr.2013.e13>. Go to original source... Go to PubMed...
    3. van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. N Engl J Med 2013; 368(5): 407-415. Go to original source... Go to PubMed...
    4. Gough E, Shaikh H, Manges AR. Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clin Infect Dis 2011; 53(10): 994-1002. Go to original source... Go to PubMed...
    5. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36(5): 580-585. Go to original source... Go to PubMed...
    6. Bakken JS, Borody T, Brandt LJ et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9(12): 1044-1049. Go to original source... Go to PubMed...
    7. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46(2): 145-149. Go to original source... Go to PubMed...
    8. Landy J, Al-Hassi HO, McLaughlin SD et al. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011; 34(4): 409-415. Go to original source... Go to PubMed...
    9. Mellow MH, Kanatzar A. Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection - results and follow-up. J Okla State Med Assoc 2011; 104(3): 89-91. Go to PubMed...
    10. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44(8): 567-570. Go to original source... Go to PubMed...
    11. Borody TJ, Paramsothy S, Agrawal G. Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions. Curr Gastroenterol Rep 2013; 15(8): 337. Go to original source... Go to PubMed...
    12. Satokari R, Fuentes S, Mattila E et al. Fecal Transplantation Treatment of Antibiotic-Induced, Noninfectious Colitis and Long-Term Microbiota Follow-Up. Case Rep Med 2014; 2014: 913867. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/913867>. Go to original source... Go to PubMed...
    13. Gustafsson A, Berstad A, Lund-Tonnesen S et al. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 1999; 34(6): 580-586. Go to original source... Go to PubMed...
    14. Gustafsson A, Lund-Tonnesen S, Berstad A et al. Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998; 33(7): 721-727. Go to original source... Go to PubMed...
    15. Hamilton MJ, Weingarden AR, Sadowsky MJ et al. Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection. Am J Gastroenterol 2012; 107(5): 761-767. Go to original source... Go to PubMed...
    16. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36(6): 503-516. Go to original source... Go to PubMed...
    17. Angelberger S, Reinisch W, Makristathis A et al. Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients after Fecal Microbiota Transplantation. Am J Gastroenterol 2013; 108(10): 1620-1630. Go to original source... Go to PubMed...
    18. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 2014; 8(12): 1569-1581. Go to original source... Go to PubMed...
    19. Quera R, Espinoza R, Estay C et al. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis 2014; 8(3): 252-253. Go to original source... Go to PubMed...
    20. Kunde S, Pham A, Bonczyk S et al. Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2013; 56(6): 597-601. Go to original source... Go to PubMed...
    21. Schwartz M, Gluck M, Koon S Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol 2013; 108(8): 1367. Go to original source... Go to PubMed...
    22. Brandt LJ, Aroniadis OC, Mellow M et al. Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. Am J Gastroenterol 2012; 107(7): 1079-1087. Go to original source... Go to PubMed...
    23. Kelly CR, de Leon L, Jasutkar N. Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients. J Clin Gastroenterol 2012; 46(2): 145-149. Go to original source... Go to PubMed...
    24. Smith MB, Kelly C, Alm EJ. Policy: How to regulate faecal transplants. Nature 2014; 506(7488): 290-291. Go to original source... Go to PubMed...
    25. Vejmelka J, Kohout P, Koten J et al. Fekální bakterioterapie a nové cesty v léčbě klostridiové střevní infekce. Prakt Lék 2014; 94(4): 195-200.
    26. Polak P, Freibergerová M, Juránková J et al. První zkušenosti s fekální bakterioterapií v léčbě relabující pseudomembranózní kolitidy způsobené Clostridium difficile. Klin Mikrobiol Inf Lék 2011; 17(6): 214-217.
    27. Sartor RB. Microbial Influences in Inflammatory Bowel Diseases. Gastroenterology 2008; 134(2): 577-594. Go to original source... Go to PubMed...
    28. Kump PK, Gröchenig H-P, Lackner S et al. Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis. Inflamm Bowel Dis 2013; 19(10): 2155-2165. Go to original source... Go to PubMed...
    29. Moayyedi P, Surette MG, Kim PT et al. Fecal Microbiota Transplantation Induces Remission in Patients with Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015; 149(1): 102-109. Go to original source... Go to PubMed...
    30. Gordon H, Harbord M. A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation. J Crohns Colitis 2014; 8(3): 256-257. Go to original source... Go to PubMed...
    31. Armougom F, Henry M, Vialettes B et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PloS One 2009; 4(9): e7125. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0007125>. Go to original source... Go to PubMed...
    32. Qin J, Li Y, Cai Z et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490(7418): 55-60. Go to original source... Go to PubMed...
    33. Vrieze A, Van Nood E, Holleman F et al. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome. Gastroenterology 2012; 143(4): 913-916. Erratum in Gastroenterology 2013; 144(1): 250. Go to original source... Go to PubMed...
    34. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146(6): 1513-1524. Go to original source... Go to PubMed...
    35. Tuohy KM, Fava F, Viola R. "The way to a man's heart is through his gut microbiota" - dietary pro- and prebiotics for the management of cardiovascular risk. Proc Nutr Soc 2014; 73(2): 172-185. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.